Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such as those made from messenger RNA (mRNA), that can be sprayed and inhaled. A ...

From the company's own site, we can see this pharma brand has a diversified portfolio of therapies across multiple clinical ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

A drug pricing expert reveals the shocking cost disparity of a life-saving spinal muscular atrophy drug in India, priced at ...

School-entry immunization requirements are a valuable strategy to reduce the spread of vaccine-preventable diseases. This research examined the temporal relationship between recommendations issued by ...

Dynavax is giving up work on its combination vaccine for tetanus, diphtheria and acellular pertussis (Tdap) after mulling phase 1 data for the shot. | Dynavax is giving up on its combination vaccine ...

Comprehensive coverage of the hexavalent vaccine can protect again whooping cough and polio writes Esther Nakkazi.

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

Pharmaceutical M&A came back with a bang during October, after a quiet September. Merck & Co (NYSE: MRK) and AbbVie (NYSE: ...

VIR's HDV and HBV treatments remain Vir's primary value drivers, with upcoming catalysts in Q4 2024 and 2025. Find out why ...

The global Latent TB Testing market is expected to grow to USD 773.4 Million by 2029, up from USD 582.5 Million in 2024, at a CAGR of 5.8% ...

All growth rates mentioned below are on a year-on-year basis and at CER. Sanofi’s Biopharma segment includes Pharma and Vaccines. Biopharma sales rose 16.6% in the quarter to €12.17 billion. Pharma ...